首页> 外国专利> Method for Inhibiting Cellular Na+-K+ ATPase Activity

Method for Inhibiting Cellular Na+-K+ ATPase Activity

机译:抑制细胞Na + -K + ATPase活性的方法

摘要

The present invention discloses an inhibitive effect of Na+—K+-ATPase caused by a compound selected from the group consisting of magnesium lithospermate B (MLB), isomer, prodrug, derivative, pharmaceutically acceptable salt, and a composition thereof. In this invention, the variations of Na+—K+-ATPase activity were monitored with increasing MLB concentrations, and the result shows the Na+—K+ ATPase activity is repressed by MLB. An outcome of the inhibitory effect, the function of cellular sodium/potassium exchanger is reduced and cellular calcium ion concentration is increased. The cerebral ischemia test exhibited MLB provides an effective repression of cell infarct. That is, the MLB is useful for inhibiting the function of cellular Na+—K+ pump, and further brings the utility for cardiac stimulation, diuretic enhancement, heart failure curing, anti-anoxia, neurocyte apoptosis protection, apoplexy prevention and treatment, and so on.
机译:本发明公开了由选自以下组成的组的化合物对Na + -K + -ATPase的抑制作用:紫草酸镁B(MLB),异构体,前药衍生物,药学上可接受的盐及其组合物。在本发明中,通过增加MLB浓度监测Na + -K + -ATPase活性的变化,结果表明Na + MLB抑制-K + ATPase的活性。抑制作用的结果是,细胞钠/钾交换剂的功能降低,细胞钙离子浓度增加。脑缺血试验显示,MLB可有效抑制细胞梗塞。也就是说,MLB可用于抑制细胞Na + -K + 泵的功能,并进一步为心脏刺激,利尿剂改善,心力衰竭治疗,抗缺氧,神经细胞凋亡保护,中风防治等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号